120 related articles for article (PubMed ID: 38417133)
1. Risk factors associated with hepatitis D virus infection and preventive strategies in Mongolia.
Su CW; Ochirkhuree B; Namdag B; Badamnachin B; Ganbold S; Gidaagaya S; Ganbold A; Yang SS; Duger D; Wu JC
J Chin Med Assoc; 2024 May; 87(5):480-487. PubMed ID: 38417133
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
3. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
7. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.
Chen X; Oidovsambuu O; Liu P; Grosely R; Elazar M; Winn VD; Fram B; Boa Z; Dai H; Dashtseren B; Yagaanbuyant D; Genden Z; Dashdorj N; Bungert A; Dashdorj N; Glenn JS
Hepatology; 2017 Dec; 66(6):1739-1749. PubMed ID: 27880976
[TBL] [Abstract][Full Text] [Related]
8. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.
Dambadarjaa D; Mukhtar Y; Tsogzolbaatar EO; Khuyag SO; Dayan A; Oyunbileg NE; Shagdarsuren OE; Nyam G; Nakamura Y; Takahashi M; Okamoto H
J Prev Med Public Health; 2022 May; 55(3):263-272. PubMed ID: 35678000
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
11. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia.
Kurbanov F; Tanaka Y; Elkady A; Oyunsuren T; Mizokami M
J Viral Hepat; 2007 Sep; 14(9):667-74. PubMed ID: 17697020
[TBL] [Abstract][Full Text] [Related]
12. Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis.
Baatarkhuu O; Lee HW; George J; Munkh-Orshikh D; Enkhtuvshin B; Ariunaa S; Eslam M; Ahn SH; Han KH; Kim DY
Clin Mol Hepatol; 2017 Jun; 23(2):147-153. PubMed ID: 28535669
[TBL] [Abstract][Full Text] [Related]
13. Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan.
Lee CY; Tsai HC; Lee SS; Wu KS; Sy CL; Chen JK; Chen YS
J Microbiol Immunol Infect; 2015 Feb; 48(1):20-7. PubMed ID: 24064291
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
[TBL] [Abstract][Full Text] [Related]
17. Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.
Engle RE; De Battista D; Danoff EJ; Nguyen H; Chen Z; Lusso P; Purcell RH; Farci P
mBio; 2020 Nov; 11(6):. PubMed ID: 33203756
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults.
Komas NP; Ghosh S; Abdou-Chekaraou M; Pradat P; Al Hawajri N; Manirakiza A; Laghoe GL; Bekondi C; Brichler S; Ouavéné JO; Sépou A; Yambiyo BM; Gody JC; Fikouma V; Gerber A; Abeywickrama Samarakoon N; Alfaiate D; Scholtès C; Martel N; Le Gal F; Lo Pinto H; Amri I; Hantz O; Durantel D; Lesbordes JL; Gordien E; Merle P; Drugan T; Trépo C; Zoulim F; Cortay JC; Kay AC; Dény P
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006377. PubMed ID: 29698488
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania.
Mansour W; Malick FZ; Sidiya A; Ishagh E; Chekaraou MA; Veillon P; Ducancelle A; Brichler S; Le Gal F; Lo B; Gordien E; Lunel-Fabiani F
J Med Virol; 2012 Aug; 84(8):1186-98. PubMed ID: 22711346
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of hepatitis B and Delta virus strains that spread in the Mediterranean North East Coast of Tunisia.
Yacoubi L; Brichler S; Mansour W; Le Gal F; Hammami W; Sadraoui A; Ben Mami N; Msaddek A; Cheikh I; Triki H; Gordien E
J Clin Virol; 2015 Nov; 72():126-32. PubMed ID: 26513762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
